Business Context and Reporting Period
This Form 8-K, dated March 10, 2023, reports on the results of a special meeting of shareholders held by NioCorp Developments Ltd. The filing details the approval of proposals related to a proposed business combination with GX Acquisition Corp. II (GXII) and associated financing arrangements with Yorkville Advisors Global, LP.
Key Financial Metrics and Voting Results
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or debt levels, as it focuses on corporate governance and transaction approvals. However, it provides specific voting data as of the record date of February 1, 2023:
- Shares Outstanding: 282,466,201 Common Shares.
- Shares Represented at Meeting: 114,892,191 Common Shares.
- Proposal 1 (Share Issuance for Transactions): Approved with 110,565,875 votes For, 2,728,919 Against, and 1,597,397 Abstentions.
- Proposal 2 (Yorkville Equity Financing): Approved with 110,346,350 votes For, 2,559,143 Against, and 1,986,698 Abstentions.
- Proposal 3 (Yorkville Convertible Debt Financing): Approved with 110,465,612 votes For, 2,573,620 Against, and 1,852,959 Abstentions.
- Proposal 4 (Quorum Amendment): Approved with 110,267,696 votes For, 2,784,406 Against, and 1,840,089 Abstentions.
Material Changes and Transaction Details
The primary material event is the shareholder approval of the Business Combination Agreement with GXII. Key terms include:
- Exchange Ratio: Pre-combination public stockholders of GXII will receive NioCorp common shares at a fixed ratio of 11.1829212 shares for each GXII Class A common share held and not redeemed.
- Corporate Structure: GXII will become a subsidiary of NioCorp (successor to Elk Creek Resources Corporation).
- Board Composition: Post-closing, NioCorp's Board will include two directors from pre-combination GXII.
- Financing: Shareholders approved a Standby Equity Purchase Agreement and a Securities Purchase Agreement for convertible debentures with Yorkville.
- Listing: NioCorp expects to undertake a reverse stock split and list on the Nasdaq Stock Market following the closing.
Outlook, Risks, and Contingencies
Management commentary and forward-looking statements highlight several critical risks and contingencies:
- Transaction Completion: The closing is contingent on regulatory approvals, third-party approvals, and the consummation of financing with Yorkville.
- Redemptions: There is a risk that redemptions by GXII public stockholders may exceed expectations, reducing the cash available to NioCorp.
- Capital Requirements: NioCorp notes a requirement for significant additional capital and a history of losses, raising questions about its ability to operate as a going concern without the transaction proceeds.
- Project Risks: Risks include the ability to secure project financing for the Elk Creek Project, commodity price fluctuations, supply chain issues, and the speculative nature of mineral exploration.
- Legal and Operational: Potential litigation, termination fees, and disruptions to current plans are cited as material uncertainties.
Investor Verification Checklist
- Verify the final redemption rate of GXII public stockholders to assess the actual cash proceeds available to NioCorp.
- Confirm the closing date of the Business Combination and the subsequent listing on Nasdaq.
- Review the definitive terms of the Standby Equity Purchase Agreement and Convertible Debentures with Yorkville to understand dilution and debt obligations.
- Monitor regulatory approvals required for the transaction in both the U.S. and Canada.
- Assess NioCorp's updated capitalization table post-transaction to understand the ownership structure and the impact of the reverse stock split.